Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Dev Neurosci ; 34(2-3): 277-87, 2012.
Article in English | MEDLINE | ID: mdl-22832166

ABSTRACT

Pelizaeus-Merzbacher-like disease is characterized by impaired psychomotor development, ataxia, progressive spasticity and mental retardation. It is induced by mutations in the gap junction gene GJC2 that encodes for the gap junction protein connexin 47. Mice bearing a human Cx47M283T missense mutation have been generated as a transgenic mouse model of Pelizaeus-Merzbacher-like disease. Homozygous expression of the mutant connexin 47 gene in oligodendrocytes resulted in a complex and variable neuropathologic phenotype, which was associated with impairments in motor coordination in juvenile, but not adult mice. In the present study, we have investigated anxiety-like behaviour and spatial working memory in juvenile (P23) and adult (3-month-old) Cx47M282T mutant mice. Adult Cx47M282T mice were also evaluated in terms of neuromotor functions and in the novel object recognition test. Juvenile Cx47M282T mutant mice exhibited an increase in anxiety-like behaviour in the open field test, but no changes in spatial working memory performance. No significant changes in anxiety-like behaviour, spatial working memory or neuromotor functions were observed in the adult Cx47M282T mutant mice. However, novel object recognition was significantly impaired in adult Cx47M282T mice. Our results suggest that the expression of the human Cx47M282T mutation in the mouse causes changes in anxiety-like behaviour in juvenile and novel object recognition impairments in adult mice. It appears that the distortion of panglial gap junction coupling in white and grey matter tissue in the Cx47M282T mice is associated with a complex age-dependent behavioural phenotype including changes in psychomotor, emotional and memory functions.


Subject(s)
Anxiety/genetics , Behavior, Animal/physiology , Connexins/genetics , Recognition, Psychology/physiology , Age Factors , Animals , Anxiety/metabolism , Connexins/metabolism , Disease Models, Animal , Gap Junctions/genetics , Gap Junctions/metabolism , Memory, Short-Term/physiology , Mice , Mutation , Pelizaeus-Merzbacher Disease/genetics , Pelizaeus-Merzbacher Disease/metabolism
2.
J Neurosci ; 29(32): 10144-52, 2009 Aug 12.
Article in English | MEDLINE | ID: mdl-19675248

ABSTRACT

Presenilin 1 (PS1) mutations are responsible for a majority of early onset familial Alzheimer's disease (FAD) cases, in part by increasing the production of Abeta peptides. However, emerging evidence suggests other possible effects of PS1 on synaptic dysfunction where PS1 might contribute to the pathology independent of Abeta. We chose to study the L286V mutation, an aggressive FAD mutation which has never been analyzed at the electrophysiological and morphological levels. In addition, we analyzed for the first time the long term effects of wild-type human PS1 overexpression. We investigated the consequences of the overexpression of either wild-type human PS1 (hPS1) or the L286V mutated PS1 variant (mutPS1) on synaptic functions by analyzing synaptic plasticity and associated spine density changes from 3 to 15 months of age. We found that mutPS1 induces a transient increase observed only in 4- to 5-month-old mutPS1 animals in NMDA receptor (NMDA-R)-mediated responses and LTP compared with hPS1 mice and nontransgenic littermates. The increase in synaptic functions is concomitant with an increase in spine density. With increasing age, however, we found that the overexpression of human wild-type PS1 progressively decreased NMDA-R-mediated synaptic transmission and LTP, without neurodegeneration. These results identify for the first time a transient increase in synaptic function associated with L286V mutated PS1 variant in an age-dependent manner. In addition, they support the view that the PS1 overexpression promotes synaptic dysfunction in an Abeta-independent manner and underline the crucial role of PS1 during both normal and pathological aging.


Subject(s)
Aging , Dendritic Spines/physiology , Hippocampus/physiology , Neuronal Plasticity/physiology , Neurons/physiology , Presenilin-1/metabolism , Alzheimer Disease/genetics , Animals , Cell Death , Dendritic Spines/genetics , Disease Models, Animal , Hippocampus/cytology , Humans , In Vitro Techniques , Long-Term Potentiation/genetics , Long-Term Potentiation/physiology , Male , Mice , Mice, Transgenic , Mutation, Missense , Neuronal Plasticity/genetics , Neurons/cytology , Presenilin-1/genetics , Receptors, N-Methyl-D-Aspartate/metabolism , Synapses/genetics , Synapses/physiology , Synaptic Transmission/genetics , Synaptic Transmission/physiology
3.
Rev Neurosci ; 21(4): 239-50, 2010.
Article in English | MEDLINE | ID: mdl-21086758

ABSTRACT

Mutations in presenilin 1 gene (PS1) account for the majority of early-onset familial Alzheimer's disease (FAD) cases. The disease is characterized by intracellular neurofibrillary tangles and extracellular amyloid fibrils composed of amyloid beta peptides (Abeta). Two successive cleavages are necessary to free the Abeta peptide from the amyloid precursor protein (APP). Gamma-secretase catalyzes the final cleavage of APP to generate Abeta peptides. PS1 is a catalytic subunit of gamma-secretase and is also involved in the cleavage of many membrane proteins. PS1 also has functional interactions with many other proteins. The use of animal models of AD has initiated the deciphering of these molecular pathways and mechanisms. Transgenic mouse models are useful to study the features of FAD and to investigate the nature of the neural-tissue changes of the disease and their evolution during aging. When expressed alone, mutations in human PS1 do not induce any detectable lesions, although they do increase Abeta peptides. This absence has led to the criticism that PS1 mouse models are not valuable for the study of AD. In this review we present how studies using PS1 transgenic mice have raised new questions related to pathological mechanisms of AD and are useful models for the study of (1) progressive cognitive decline, (2) early-occurring synaptic dysfunction, and (3) mechanisms other than amyloidogenesis that can be involved in disease pathogenesis.


Subject(s)
Aging , Presenilin-1/genetics , Synapses/pathology , Aging/genetics , Aging/metabolism , Alzheimer Disease/genetics , Alzheimer Disease/pathology , Animals , Disease Models, Animal , Humans , Mice , Mice, Transgenic
4.
Exp Gerontol ; 42(10): 951-62, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17596899

ABSTRACT

In Alzheimer's disease there is an increased production of the toxic beta-amyloid peptides (Abeta), especially the longer forms such as Abeta(1-42). Using the patch-clamp technique we have studied the contribution of early pro-inflammatory processes to the acute effects of 1 microM Abeta(1-42) on the parallel fiber EPSC (PF-EPSC) of Purkinje cells in cerebellar slices. Abeta(1-42) induces a decrease in the PF-EPSC amplitude. This decrease is accompanied by a decrease in the frequency and amplitude of the miniature EPSCs, suggesting that Abeta acts at both pre- and post-synaptic sites. In the presence of L-NAME, a nitric oxide synthase inhibitor, the effects of Abeta were partially blocked. The frequency of mEPSCs was unchanged while Abeta still reduced the mEPSCs amplitude. The anti-inflammatory agent flurbiprofen blocked the depressant action of Abeta on the mEPSCs amplitude but not its effect on mEPSCs frequency. Both a p38 inhibitor (SB203580) and a JNK inhibitor (SP600125) reverse the effects of Abeta as an increase in the mEPSCs frequency and amplitude was observed. This study provides evidence that the Abeta-induced depression of the PF-EPSCs was mediated via an activation of JNK and p38 and by the action of NO and raises the possibility of the involvement of an early pro-inflammatory process.


Subject(s)
Amyloid beta-Peptides/pharmacology , Inflammation/physiopathology , Peptide Fragments/pharmacology , Purkinje Cells/drug effects , Amyloid beta-Peptides/antagonists & inhibitors , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Enzyme Inhibitors/pharmacology , Excitatory Postsynaptic Potentials/drug effects , Flurbiprofen/pharmacology , Glutamic Acid/metabolism , Mice , Mice, Inbred C57BL , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase/physiology , Patch-Clamp Techniques , Peptide Fragments/antagonists & inhibitors , Purkinje Cells/physiology , Receptors, Nicotinic/drug effects , Receptors, Nicotinic/physiology , Signal Transduction , Synapses/drug effects , Synapses/physiology , Tissue Culture Techniques , alpha7 Nicotinic Acetylcholine Receptor
5.
J Comp Neurol ; 449(1): 65-75, 2002 Jul 15.
Article in English | MEDLINE | ID: mdl-12115693

ABSTRACT

In immature rats, Purkinje cells receive synapses from multiple climbing fibers. During development, this multi-innervation regresses and only one climbing fiber innervates each Purkinje cell in the adult. The multi-innervation of immature rats is maintained in the adult if the precursors of the cerebellar granule cells are destroyed by early postnatal X-irradiation. The present study was undertaken to determine the origin of climbing fibers projecting to lobule VI-VII of the cerebellum in X-irradiated granuloprival rats. Olivary neurons were labelled by retrograde transport of wheat germ agglutinin conjugated to horseradish peroxidase, which was injected by iontophoresis in the right vermis of lobule VI-VII. Three-dimensional reconstructions of the inferior olive were made for granuloprival and control rats. No significant variation in the shape and dimension of the olive was observed between the two groups. Labeled cells were found in the middle part of the median accessory olive (MAO). In control rats, stained cells were found only in the contralateral MAO, whereas in the granuloprival rats they were located in both the contralateral and the ipsilateral MAO. Homologous zones were marked in control and granuloprival rats in the middle part of MAO. In granuloprival rats, there was a symmetry in the distribution of the stained cells in the ipsi- and contralateral MAO along the three axes. Therefore, polyinnervation involves homologous regions of both inferior olivary nuclei.


Subject(s)
Cerebellar Cortex/chemistry , Cerebellar Cortex/physiology , Horseradish Peroxidase/analysis , Olivary Nucleus/chemistry , Olivary Nucleus/physiology , Animals , Axonal Transport/physiology , Brain Mapping/methods , Cerebellar Cortex/radiation effects , Iontophoresis , Neural Pathways/chemistry , Neural Pathways/physiology , Neural Pathways/radiation effects , Neurons/enzymology , Neurons/physiology , Olivary Nucleus/radiation effects , Rats , Rats, Wistar , X-Rays
6.
J Alzheimers Dis ; 19(3): 1021-33, 2010.
Article in English | MEDLINE | ID: mdl-20157256

ABSTRACT

Presenilin 1 (PS1) mutations are responsible for many early-onset familial Alzheimer's disease (FAD) cases. While increasing evidence points to impaired synaptic plasticity as an early event in AD, PS1 mutant mice exhibit a paradoxical increase in hippocampal long-term potentiation (LTP). Among PS1 mouse models, PS1 M146V mutant knock-in mice (PS1KI) are particularly interesting in that they exhibit memory impairment in spatial tasks. Here we investigated the effects of aging on two forms of LTP in PS1KI mice, the widely-studied early phase of LTP (E-LTP) and a particular form of LTP called late-LTP (L-LTP) which requires transcription and protein synthesis. L-LTP is thought to be critical for long-term memory. We found a lower L-LTP maintenance phase in PS1KI mice compared to wild type littermates at 3 months of age. As the mice age, they exhibit impairment of both the induction and maintenance phases of LTP. When E-LTP and NMDA receptor-mediated transmission were analyzed, PS1KI mice displayed an increase at 3 months compared to wild type littermates; this difference did not persist at older ages and finally decreased at 12 months. These results reveal an L-LTP decrease in PS1 mutant mice at an early stage, which occurs coincidently with a paradoxical enhancement of E-LTP. The observation of a decrease in both forms of LTP during aging supports the view that PS1KI mice are a valuable model for the study of age-dependent synaptic dysfunction and cognitive decline in AD.


Subject(s)
Alzheimer Disease/genetics , Alzheimer Disease/physiopathology , Brain/physiopathology , Presenilin-1/genetics , Aging/physiology , Animals , Disease Progression , Hippocampus/physiopathology , Long-Term Potentiation , Mice , Mice, Mutant Strains , Point Mutation/genetics
7.
Biochem Biophys Res Commun ; 296(5): 1317-21, 2002 Sep 06.
Article in English | MEDLINE | ID: mdl-12207918

ABSTRACT

The acute effects of beta-amyloid (25-35) and (1-40) on high voltage activated calcium channels were compared in CA1 pyramidal cells of adult mouse hippocampal slices using the whole-cell patch-clamp recording. Bath application of oligomeric beta-amyloid (25-35) reversibly increased the barium current (I(Ba)) to 1.61 (normalized amplitude), while oligomeric beta-amyloid (1-40) reversibly enhanced the I(Ba) to 1.74. Reverse-sequence beta-amyloid [(35-25) and (40-1)] had no effect. The effect of beta-amyloid (25-35) was blocked by nifedipine, a selective antagonist of L-type calcium channels. In contrast, the effect of beta-amyloid (1-40) was not blocked by nifedipine and I(Ba) was enhanced to 4.96. It is concluded that these oligomeric peptides may act through different types of calcium channels and/or receptors. The toxicity of Abeta(25-35) implicates a potentiation of L-type calcium channels while the one of Abeta(1-40) is related to an increase of non-L-type calcium channels, which may involve an increase in transmitter release.


Subject(s)
Amyloid beta-Peptides/pharmacology , Calcium Channels/physiology , Hippocampus/cytology , Peptide Fragments/pharmacology , Pyramidal Cells/physiology , Amyloid beta-Peptides/antagonists & inhibitors , Animals , Barium/metabolism , Calcium Channel Blockers/pharmacology , Calcium Channels, L-Type/physiology , Cells, Cultured , Electric Conductivity , Kinetics , Mice , Nifedipine/pharmacology , Peptide Fragments/antagonists & inhibitors , Pyramidal Cells/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL